
Espen Saxhaug Kristoffersen
@espnsaxkristoff
Neurologist, associate professor, Stroke, ICH, Cerebral Venous Thrombosis, Migraine, primary care, Arsenal, Music
ID: 1530087613
19-06-2013 07:30:48
111 Tweet
205 Followers
237 Following

So honoured our planned MAX-ICH pilot study 🧠🩸 received the IAM award 2024 for best research project. Thanks to European Stroke Org and organisers Laurent Puy, Andrea Morotti & Thorsten Steiner. Would not be possible without David Seiffge @researchbern 🙏🏻


Martina Göldlin from Stroke Research Center Bern presenting the results from EURECA at European Stroke Org #ESOC2024 on timing and location of recurrent ICH. Great team effort Espen Saxhaug Kristoffersen Christian H Nolte Laurent Puy Simon Fandler-Höfler UCL Stroke Research



Main stage at #ESOC2024 for David Seiffge elucidating options for #IVT in patients with recent #DOAC intake. Interest in joining Stroke Research Center Bern's efforts in the prospective RCT and registry efforts? DM DO-IT Trial


Preparing for my talk about #breakthroughstrokes at the Norwegian Stroke Meeting in Bergen tomorrow with my friend Espen Saxhaug Kristoffersen. Deep breath of beautiful Norwegian nature! Looking forward to discuss ELAPSE and DO-IT Trial Guri Hagberg Thomas Meinel Stroke Research Center Bern Else C. Sandset


That’s a great programme connecting stroke enthusiasts! We were lucky to welcome many brillant young doctors at Stroke Research Center Bern Insel Gruppe over the last years - please get in touch if you are interested Urs Martin Fischer Thomas Meinel European Stroke Master Martina Göldlin Bernhard Siepen Espen Saxhaug Kristoffersen

Great start for the 12th ESO-ESMINT Stroke Winterschool in Bern with our president Simona Sacco on the global burden of stroke European Stroke Org ESMINT Society Stroke Research Center Bern Thomas Meinel Urs Martin Fischer Tomas Dobrocky Eike Piechowiak Espen Saxhaug Kristoffersen Insel Gruppe Adnan Mujanović


Thanh Lam "Lance" Tran The use of anti-Xa activity cut-off of <0.5IU is not supported by any data. It was introduced in the ESO guidelines based on „expert“ opinion. Just DO-IT Trial Stroke Research Center Bern Thomas Meinel Jan Purrucker Teddy Wu Ashkan Shoamanesh Luciana Catanese, MD Aristeidis Katsanos Espen Saxhaug Kristoffersen


EURECA: New data on recurrent ICH: every second recurrence is adjacent to index ICH. Those bleedings occur early and are strongly associated with CAA. Great collaboration lead by Martina Göldlin Stroke Research Center Bern Author interview podcast: edhub.ama-assn.org/jn-learning/au… jamanetwork.com/journals/jaman…

Exciting News! Many thanks to our funding partners Schweizerischer Nationalfonds (SNF) and Helmut Horten Stiftung for funding our clinical trial #DOIT 🙏 Site openings all across 🇨🇭 are following. Stay tuned for updates as we prepare to launch 🇪🇺🌍 in 2025!

Great news! We recruited the first patient in our DO-IT Trial in Stroke Research Center Bern ! Well done by our tremendous team! Big thanks to our funders Schweizerischer Nationalfonds (SNF) ! Thomas Meinel Urs Martin Fischer Ashkan Shoamanesh Luciana Catanese, MD Aristeidis Katsanos Luciano Sposato 🇦🇷🇨🇦 Jan Purrucker Teddy Wu Espen Saxhaug Kristoffersen

A multidisciplinary headache team effectively reduces headache frequency, sick leave, and psychological distress in patients with present or recurrent headache-related sick leave. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience Espen Saxhaug Kristoffersen



1 in 4 ICHs are linked to oral anticoagulants 🧠🩸💊 Check out our publication in reviewing current evidence on reversal strategies for VKA-, direct thrombin-, and factor Xa inhibitor-associated ICH. journals.sagepub.com/doi/10.1177/23… David Seiffge Stroke Research Center Bern Urs Martin Fischer European Stroke Org


European Stroke Org special issue on OAC-ICH was just published: ow.ly/ZJ0s50VWrAC Together with Thorsten Steiner and a team of renowned experts, we summarize latest evidence on several aspects of OAC-ICH Management Bernhard Siepen Ashkan Shoamanesh Sven Poli Espen Saxhaug Kristoffersen Stroke Research Center Bern

Espen Saxhaug Kristoffersen on therapeutic strategies in the patients with ischemic stroke despite oral anticoagulation. There is no established treatment to reduce the high risk of recurrence. Switch of anticoagulation is not beneficial. There is a need to enrol patients in RCT. #ESOC2025


Delighted to have presented the results from the CERES TANDEM study in plenary session European Stroke Org #ESOC2025 Thanks the Steering C & all collaborators Thanh Nguyen 🇺🇦 Carlos Molina Francesco Diana Diana Aguiar de Sousa Aristeidis Katsanos Adnan Mujanović Adnan H. Siddiqui, MD Andrea Zini Elena Zapata-Arriaza
